REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER

Clinical trial NCT06826677 · COMPLETED

Trial details

NCT number: NCT06826677
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Small Cell Lung Carcinoma

Start date: 2024-07-30
Primary completion: 2025-01-23
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.